265,000 Shares of NewHold Investment Corp IV $NHIV Purchased by Periscope Capital Inc.

Periscope Capital Inc. bought a new stake in shares of NewHold Investment Corp IV (NASDAQ:NHIV – Free Report) during the third quarter, Holdings Channel.com reports. The fund bought 265,000 shares of the company’s stock, valued at approximately $2,676,000.

Separately, Moore Capital Management LP acquired a new position in NewHold Investment Corp IV in the 2nd quarter worth about $7,000,000.

NewHold Investment Corp IV Stock Performance

Shares of NASDAQ:NHIV opened at $9.97 on Monday. NewHold Investment Corp IV has a 1 year low of $9.80 and a 1 year high of $11.50. The company’s 50 day simple moving average is $10.08.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings began coverage on NewHold Investment Corp IV in a research report on Tuesday, September 1st. They set a “sell (e)” rating on the stock. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat, NewHold Investment Corp IV currently has a consensus rating of “Sell”.

Get Our Latest Research Report on NHIV

NewHold Investment Corp IV Profile

(Free Report)

NewHold Investment Corp IV is a special purpose acquisition company, or blank-check company. It was formed to pursue a merger, share exchange, asset acquisition, or other business combination with one or more businesses. Until it completes a business combination, NewHold Investment Corp IV does not have significant operating activities and does not offer its own products or services. The company has not identified a specific target in the information available.

Featured Articles

Want to see what other hedge funds are holding NHIV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NewHold Investment Corp IV (NASDAQ:NHIV – Free Report).

Receive News & Ratings for NewHold Investment Corp IV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewHold Investment Corp IV and related companies with MarketBeat.com's FREE daily email newsletter.